Atlas Trials

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Clinical trial NCT00460382 · COMPLETED

Trial details

NCT number
NCT00460382
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2007-05-01
Primary completion
2008-03-01
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.